Quasi-random reflections on randomized controlled trials and comparative effectiveness research

Clinical Trials

Volumn 9, Issue 1, 2012, Pages 22-26

  Goodman, Steven N ^a  

^a STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPARATIVE EFFECTIVENESS; CONCEPTUAL FRAMEWORK; CONFERENCE PAPER; COST; OUTCOME ASSESSMENT; PRIORITY JOURNAL; QUALITY CONTROL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL;

COMPARATIVE EFFECTIVENESS RESEARCH; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84857081593     PISSN: 17407745     EISSN: 17407753     Source Type: Journal    
DOI: 10.1177/1740774511433285     Document Type: Conference Paper

References (24)

1. Noble HB. Magnets lessen foot pain of diabetics, a study finds. New York Times. 1999 ;: A16
2. Pittler MH, Brown EM, Ernst E. Static magnets for reducing pain: Systematic review and meta-analysis of randomized trials. Can Med Assoc J. 2007 ; 177: 736-42 (Pubitemid 47523554)
3. Initial National Priorities for Comparative Effectiveness Research. Washington, DC: The National Academies Press ; 2009 :
4. Tunis SR, Stryer DB, Clancy CM. Practical clinical trials: Increasing the value of clinical research for decision making in clinical and health policy. JAMA. 2003 ; 290: 1624-32 (Pubitemid 37430387)
5. Radiofrequency catheter ablation of the pulmonary veins for treatment of atrial fibrillation. Technol Eval Cent Asses Program Exec Summ. 2009 ; 23: 1-5
6. Catheter Ablation Versus Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial (CABANA). Available at http://clinicaltrials.gov/ct2/show/ NCT00911508 (accessed 14 December 2011).
7. Failure of extracranial intracranial bypass to reduce the risk of ischemic stroke: Results of an international randomized trial. N Engl J Med. 1985 ; 313: 1191-1200
8. Goldring S, Zervas N, Langfitt T. The Extracranial-Intracranial Bypass Study. A report of the committee appointed by the American Association of Neurological Surgeons to examine the study. N Engl J Med. 1987 ; 316: 817-20 (Pubitemid 17046092)
9. Merz B. Neurosurgeons address EC/IC study; question controlled surgical trials. JAMA. 1986 ; 256: 165-67
10. Powers WJ, Clarke WR, Grubb RLJ, et al. Extracranial-intracranial bypass surgery for stroke prevention in hemodynamic cerebral ischemia: The Carotid Occlusion Surgery Study randomized trial. JAMA. 2011 ; 306: 1983-92
11. Thorpe KE, Zwarenstein M, Oxman AD, et al. A pragmatic-explanatory continuum indicator summary (PRECIS): A tool to help trial designers. J Clin Epidemiol. 2009 ; 62: 464-75
12. Luce BR, Kramer JM, Goodman SN, et al. Rethinking randomized clinical trials for comparative effectiveness research: The need for transformational change. Ann Intern Med. 2009 ; 151: 206-09
13. Birkmeyer NJ, Weinstein JN, Tosteson AN, et al. Design of the Spine Patient outcomes Research Trial (SPORT). Spine. 2002 ; 27: 1361-72 (Pubitemid 34655145)
14. Weinstein JN, Lurie JD, Tosteson TD, et al. Surgical versus nonsurgical treatment for lumbar degenerative spondylolisthesis. N Engl J Med. 2007 ; 356: 2257-70 (Pubitemid 46849156)
15. VanderWeele TJ, Knol MJ. Interpretation of subgroup analyses in randomized trials: Heterogeneity versus secondary interventions. Ann Intern Med. 2011 ; 154: 680-83
16. Pham MX, Teuteberg JJ, Kfoury AG, et al. Gene-expression profiling for rejection surveillance after cardiac transplantation. N Engl J Med. 2010 ; 362: 1890-1900
17. Jarcho JA. Fear of rejection-monitoring the heart-transplant recipient. N Engl J Med. 2010 ; 362: 1932-33
18. A National Cancer Clinical Trials System for the 21st Century: Reinvigorating the NCI Cooperative Group Program. Washington, DC: National Academies Press ; 2010 :
19. Dilts DM, Sandler A, Cheng S, et al. Development of clinical trials in a cooperative group setting: The eastern cooperative oncology group. Clin Cancer Res. 2008 ; 14: 3427-33
20. Dilts DM, Sandler AB. Invisible barriers to clinical trials: The impact of structural, infrastructural, and procedural barriers to opening oncology clinical trials. J Clin Oncol. 2006 ; 24: 4545-52 (Pubitemid 46630949)
21. Dilts DM, Cheng SK, Crites JS, Sandler AB, Doroshow JH. Phase III clinical trial development: A process of chutes and ladders. Clin Cancer Res. 2010 ; 16: 5381-89
22. Dilts DM, Sandler AB, Baker M, et al. Processes to activate phase III clinical trials in a cooperative oncology group: The Case of Cancer and Leukemia Group B. J Clin Oncol. 2006 ; 24: 4553-57 (Pubitemid 46630950)
23. Dilts DM, Sandler AB, Cheng SK, et al. Steps and time to process clinical trials at the Cancer Therapy Evaluation Program. J Clin Oncol. 2009 ; 27: 1761-66
24. Berwick DM. Developing and testing changes in delivery of care. Ann Intern Med. 1998 ; 128: 651-56 (Pubitemid 28169642)